Patient characteristics associated with decisions on secondary findings and data sharing for exome and genome sequencing

ACMG 2026

Mar 10, 2026
Presentation

Kalynn Culver, Rachel Palmquist, Brianna Stebbins, Sabrina Malone Jenkins, Emily Fleming, Chelsea Solorzano, LeeAnn Dempsey

Introduction
Exome sequencing (ES) and genome sequencing (GS) have become first-line tests for pediatric patients with multiple congenital anomalies, global developmental delay, intractable epilepsy, or other acute presentations in both the inpatient and outpatient settings. ES/GS are typically sent as a trio, with the proband (patient) and both parents submitting samples when possible. For ES/GS, patients and/or their parents decide to receive or decline secondary findings, genetic test results that provide information about medically actionable variants that are unrelated to the primary reason for ordering the test. For some laboratories, parents also must decide if they would like to opt into allowing their de-identified information to be used for research by the laboratory.

 

Studies have found that there are factors that influence a person’s decision to opt into receiving secondary findings; those who are not religious, have a higher level of education, and those without Medicaid were more likely to opt into receiving secondary findings. Additionally, those who had a higher perceived need to hide genetic information from their family members and employers or to exclude it from medical records were more likely to opt out of receiving secondary findings.

 

Most of the research on preferences to receive secondary findings and factors that may affect decisions has been conducted using hypothetical scenarios in focus groups. Our study aims to analyze actual patient/parent decisions by retroactively looking at exome and genome testing that has been performed.

 

Methods
Data was obtained from the genetic testing laboratories Ambry Genetics, Rady Children’s Genomic Institute, Broad Institute, Baylor Genetics Laboratory, Labcorp, Revvity, Variantyx, GeneDx, and ARUP Laboratories for patients that have had exome sequencing and genome sequencing through University of Utah/Intermountain Children’s Health. Variables investigated include (but are not limited to): age, sex, language, race/ethnicity, familial role, collection date, type of test ordered, zip code, insurance type, and ordering provider. Chi-square tests for independence and z tests were used to determine if observed differences are due to chance or due to a relationship between variables.

 

Results
Preliminary results indicate: more probands were opted out of receiving secondary findings in the inpatient setting compared to outpatient setting. More parents also opted out of receiving secondary findings in the inpatient setting compared to outpatient setting. Evidence suggests that there are racial differences in parental opt-out rates for data sharing, especially when looking only at fathers. There is evidence to suggest that parents who are older than 50 years old were more likely to opt out of sharing data compared to younger parents.

 

Data collection and analysis are ongoing, and we anticipate more comprehensive results in the near future.

 

Conclusion
There are limited studies on factors that affect patient and parent decisions on receiving secondary findings and data sharing for exome and genome sequencing. Investigation into these differences could aid in addressing disparities and help develop more targeted communication techniques within a counseling setting.